Cardiac Effects of Micrurus corallinus and Micrurus dumerilii carinicauda (Elapidae) Venoms and Neutralization by Brazilian Coralsnake Antivenom and Varespladib
- 22 February 2023
- journal article
- research article
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 23 (3-4) , 1-15
Abstract
In this work, we examined the action of two South American coralsnake (Micrurus corallinus and Micrurus dumerilii carinicauda) venoms on rat heart function in the absence and presence of treatment with Brazilian coralsnake antivenom (CAV) and varespladib (VPL), a potent phospholipase A2 inhibitor. Anesthetized male Wistar rats were injected with saline (control) or a single dose of venom (1.5 mg/kg, i.m.) and monitored for alterations in echocardiographic parameters, serum CK-MB levels and cardiac histomorphology, the latter using a combination of fractal dimension and histopathological methods. Neither of the venoms caused cardiac functional alterations 2 h after venom injection; however, M. corallinus venom caused tachycardia 2 h after venom injection, with CAV (given i.p. at an antivenom:venom ratio of 1:1.5, v/w), VPL (0.5 mg/kg, i.p.) and CAV + VPL preventing this increase. Both venoms increased the cardiac lesional score and serum CK-MB levels compared to saline-treated rats, but only the combination of CAV + VPL prevented these alterations, although VPL alone was able to attenuate the increase in CK-MB caused by M. corallinus venom. Micrurus corallinus venom increased the heart fractal dimension measurement, but none of the treatments prevented this alteration. In conclusion, M. corallinus and M. d. carinicauda venoms caused no major cardiac functional alterations at the dose tested, although M. corallinus venom caused transient tachycardia. Both venoms caused some cardiac morphological damage, as indicated by histomorphological analyses and the increase in circulating CK-MB levels. These alterations were consistently attenuated by a combination of CAV and VPL.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2020/14191-6, 2016/11344-0, 2020/04287-6)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (309320/2016-0, 313273/2018-9)
This publication has 55 references indexed in Scilit:
- A Localizing Circumferential Compression Device Increases Survival after Coral Snake Envenomation to the Torso of an Animal ModelThe Journal of Emergency Medicine, 2011
- Individual and combined effects of subclinical doses of deoxynivalenol and fumonisins in pigletsMolecular Nutrition & Food Research, 2011
- Diversity of Micrurus Snake Species Related to Their Venom Toxic Effects and the Prospective of Antivenom NeutralizationPLOS Neglected Tropical Diseases, 2010
- Neurotoxicity ofMicrurus altirostris(Uruguayan coral snake) venom and its neutralization by commercial coral snake antivenom and specific antiserum raised in rabbitsClinical Toxicology, 2008
- Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of CardiologyJournal of the American Society of Echocardiography, 2005
- Pressure-Immobilization Bandages Delay Toxicity in a Porcine Model of Eastern Coral Snake (Micrurus fulvius fulvius) EnvenomationAnnals of Emergency Medicine, 2005
- Micrurus spixii (PERUVIAN CORAL SNAKE) VENOM - PRELIMINARY BIOCHEMICAL AND ENZYMATIC CHARACTERIZATIONJournal of Venomous Animals and Toxins including Tropical Diseases, 2002
- Toxins isolated from the venom of the brazilian coral snake (Micrurus frontalis frontalis) include hemorrhagic type phospholipases A2 and postsynaptic neurotoxinsToxicon, 1997
- Local effects induced by venoms from five species of genus Micrurus sp. (coral snakes)Toxicon, 1994
- Cardiovascular and muscular effects of venom from coral snake, Micrurus fulviusToxicon, 1971